FDA Inspection 1002028 — EMSL Analytical, Inc.
The FDA completed an inspection of EMSL Analytical, Inc. on February 23, 2017 in Cinnaminson, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 23, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Cinnaminson, NJ (United States)